{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:45:46Z","timestamp":1777574746624,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA235347"],"award-info":[{"award-number":["CA235347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009451","name":"Osteopathic Heritage Foundations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.yexcr.2021.112594","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T10:58:05Z","timestamp":1617447485000},"page":"112594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression"],"prefix":"10.1016","volume":"403","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-7217","authenticated-orcid":false,"given":"Stephanie A.","family":"Sheehan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-7479","authenticated-orcid":false,"given":"Kelly L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.","family":"Retzbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7742-9591","authenticated-orcid":false,"given":"Premalatha","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harini","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-6453","authenticated-orcid":false,"given":"Moises","family":"Lopez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shraddha","family":"Suryavanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112594_bib1","series-title":"Coronavirus Disease (COVID-19) Weekly Epidemiological Update","year":"2021"},{"key":"10.1016\/j.yexcr.2021.112594_bib2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"Virology: SARS virus infection of cats and ferrets","volume":"425","author":"Martina","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112594_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2021.112594_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell."},{"key":"10.1016\/j.yexcr.2021.112594_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.03.044","article-title":"Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses","volume":"526","author":"Qi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2021.112594_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2021.112594_bib7","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1128\/JVI.02292-10","article-title":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques","volume":"85","author":"Liu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2021.112594_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035876","article-title":"Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts","volume":"7","author":"Bertram","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112594_bib9","article-title":"Oral epithelial expression of angiotensin converting enzyme-2: implications for COVID-19 diagnosis and prognosis","author":"Srinivasan","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.yexcr.2021.112594_bib10","article-title":"Significant expression of FURIN and ACE2 on oral epithelial cells may facilitate the efficiency of 2019-nCov entry","author":"Lin","year":"2020","journal-title":"bioRXiv"},{"key":"10.1016\/j.yexcr.2021.112594_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.yexcr.2021.112594_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-020-0451-z","article-title":"COVID-19 revisiting inflammatory pathways of arthritis","volume":"16","author":"Schett","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.yexcr.2021.112594_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Tortorici","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6501","key":"10.1016\/j.yexcr.2021.112594_bib14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112594_bib15","article-title":"Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2","author":"Shajahan","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.yexcr.2021.112594_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2017.03.007","article-title":"Antiviral lectins: selective inhibitors of viral entry","volume":"142","author":"Mitchell","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.yexcr.2021.112594_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004172","article-title":"Both alpha2,3- and alpha2,6-linked sialic acids on o-linked glycoproteins act as functional receptors for porcine sapovirus","volume":"10","author":"Kim","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2021.112594_bib18","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.18632\/oncotarget.3515","article-title":"Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms","volume":"6","author":"Ochoa-Alvarez","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2021.112594_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041845","article-title":"Plant lectin can target receptors containing sialic Acid, exemplified by podoplanin, to inhibit transformed cell growth and migration","volume":"7","author":"Ochoa-Alvarez","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112594_bib20","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/glycob\/cwr080","article-title":"Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities","volume":"21","author":"Geisler","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.yexcr.2021.112594_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/biom10040637","article-title":"New therapeutic strategies for osteoarthritis by targeting sialic acid receptors","volume":"10","author":"Carpintero-Fernandez","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.yexcr.2021.112594_bib22","series-title":"Using MASL to Combat Oral Cancer","author":"NCT04188665","year":"2020"},{"key":"10.1016\/j.yexcr.2021.112594_bib23","doi-asserted-by":"crossref","first-page":"18914","DOI":"10.1074\/jbc.M608980200","article-title":"Src utilizes Cas to block gap junctional communication mediated by connexin43","volume":"282","author":"Shen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112594_bib24","article-title":"Two distinct trophectoderm lineage stem cells from human pluripotent stem cells","author":"Mischler","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.yexcr.2021.112594_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1158\/0008-5472.CAN-03-2558","article-title":"Normal cells control the growth of neighboring transformed cells independent of gap junctional communication and SRC activity","volume":"64","author":"Alexander","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.yexcr.2021.112594_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/np300893n","article-title":"Cytotoxicity and modulation of cancer-related signaling by (Z)- and (E)-3,4,3',5'-tetramethoxystilbene isolated from Eugenia rigida","volume":"76","author":"Zaki","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.yexcr.2021.112594_bib27","first-page":"923","article-title":"Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2\/LYT-10","volume":"9","author":"Chang","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2021.112594_bib28","volume":"vol. 64","author":"Jeon","year":"2020"},{"key":"10.1016\/j.yexcr.2021.112594_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2021.112594_bib30","first-page":"400","article-title":"Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma","volume":"8","author":"Yamanouchi","year":"2018","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.yexcr.2021.112594_bib31","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3892\/ijo.2014.2270","article-title":"Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes","volume":"44","author":"Harada","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2021.112594_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drudis.2018.07.009","article-title":"Src and podoplanin forge a path to destruction","volume":"24","author":"Krishnan","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yexcr.2021.112594_bib33","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/biom5031783","article-title":"Challenges in antibody development against tn and sialyl-tn antigens","volume":"5","author":"Loureiro","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.yexcr.2021.112594_bib34","doi-asserted-by":"crossref","first-page":"12196","DOI":"10.1038\/s41598-018-30421-w","article-title":"Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids","volume":"8","author":"Loureiro","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112594_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: a new virus, but a familiar receptor and cytokine release syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2021.112594_bib36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.118.10266","article-title":"Understanding angiotensin II type 1 receptor signaling in vascular pathophysiology","volume":"71","author":"Eguchi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.yexcr.2021.112594_bib37","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","article-title":"Pleiotropy and specificity: insights from the interleukin 6 family of cytokines","volume":"50","author":"Murakami","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2021.112594_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.yexcr.2021.112594_bib39","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.18632\/oncotarget.22814","article-title":"IL-36 cytokines in autoimmunity and inflammatory disease","volume":"9","author":"Ding","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2021.112594_bib40","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.171.6.3194","article-title":"IL-6 induces NF-kappa B activation in the intestinal epithelia","volume":"171","author":"Wang","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2021.112594_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coi.2016.06.003","article-title":"Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question","volume":"42","author":"Gopalakrishnan","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.yexcr.2021.112594_bib42","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/jiw152","article-title":"Role of interleukin 36gamma in host defense against tuberculosis","volume":"214","author":"Ahsan","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.yexcr.2021.112594_bib43","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jid.2016.03.020","article-title":"IL-36gamma is involved in psoriasis and allergic contact dermatitis","volume":"136","author":"Balato","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.yexcr.2021.112594_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cvr\/cvq076","article-title":"The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation","volume":"86","author":"Brasier","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2021.112594_bib45","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.yexcr.2021.112594_bib46","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/qjmed\/hcz206","article-title":"Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-kappaB and Nrf2 pathways","volume":"112","author":"Fang","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.yexcr.2021.112594_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1523-1755.2005.00424.x","article-title":"NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria","volume":"68","author":"Takase","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2021.112594_bib48","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.3389\/fimmu.2019.02530","article-title":"Mucosal immunity and the FOXO1 transcription factors","volume":"10","author":"Graves","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2021.112594_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cyto.2017.08.022","article-title":"IL-36 induces cytokine IL-6 and chemokine CXCL8 expression in human lung tissue cells: implications for pulmonary inflammatory responses","volume":"99","author":"Zhang","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.yexcr.2021.112594_bib50","doi-asserted-by":"crossref","first-page":"16374","DOI":"10.1074\/jbc.M110.207738","article-title":"Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression","volume":"286","author":"Piantadosi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112594_bib51","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3389\/fimmu.2019.02532","article-title":"Biology of IL-36 signaling and its role in systemic inflammatory diseases","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2021.112594_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chest.2020.03.032","article-title":"Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1","volume":"158","author":"Tang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.yexcr.2021.112594_bib56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2021.112594_bib57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: risk for cytokine targeting in chronic inflammatory diseases?","volume":"20","author":"Schett","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2021.112594_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","article-title":"COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?","volume":"38","author":"Sarzi-Puttini","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.yexcr.2021.112594_bib59","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2021.112594_bib60","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(20)31129-6","article-title":"Kawasaki-like disease: emerging complication during the COVID-19 pandemic","volume":"395","author":"Viner","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2021.112594_bib61","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2021.112594_bib62","doi-asserted-by":"crossref","first-page":"100418","DOI":"10.1016\/j.eclinm.2020.100418","article-title":"Tocilizumab for treatment of patients with severe COVID-19: a retrospective cohort study","volume":"24","author":"Kewan","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.yexcr.2021.112594_bib63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2352-4642(20)30177-2","article-title":"COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study","volume":"4","author":"Gotzinger","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.yexcr.2021.112594_bib64","first-page":"1","article-title":"An update on current therapeutic drugs treating COVID-19","author":"Wu","year":"2020","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.yexcr.2021.112594_bib65","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2741\/2750","article-title":"Uses of plant lectins in bioscience and biomedicine","volume":"13","author":"Pusztai","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.yexcr.2021.112594_bib66","first-page":"285","article-title":"Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins","volume":"21","author":"Pryme","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.yexcr.2021.112594_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2006.11.030","article-title":"Galectins - potential targets for cancer therapy","volume":"253","author":"Hasan","year":"2007","journal-title":"Canc. Lett."},{"key":"10.1016\/j.yexcr.2021.112594_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/v10100515","article-title":"Human coronavirus infections in Israel: epidemiology, clinical symptoms and summer seasonality of HCoV-HKU1","volume":"10","author":"Friedman","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.yexcr.2021.112594_bib69","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Expert group for, clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2021.112594_bib70","first-page":"E46","article-title":"Maackia amurensis seed lectin can suppress IL-22induced hyperproliferative reconstituted epidermis","volume":"86","author":"Honma","year":"2017","journal-title":"Journal of Dermatalogical Science"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721001269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721001269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:23:14Z","timestamp":1777404194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721001269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0014482721001269"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112594","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112594"}}